The antitumoral effect of statins in pancreatic ductal adenocarcinoma: a scoping review
Artículo
Acceso abierto
Artículo
DOAJ
IntroductionPancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive and invasive malignancies, with limited response to the currently available systemic therapy options. Having a 5-year survival of 12%...
LCC LCC:Therapeutics. PharmacologyIdioma eng
Acceso abiertoRuta libre sin proxy. Acceso recomendado cuando no hay suscripción activa.
Open Access